Proteona Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 14

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Proteona General Information

Description

Operator of a precision medicine platform intended to use single-cell multi-omics to improve clinical outcomes in cancer. The company's single-cell multi-omics platform uses DNA barcoded antibodies to provide both proteomic and genomic information from the same single cells, enabling users to phenotype cells using standard protein markers and gain a deep understanding of cell activity based upon gene expression profiles.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2 Jurong East, Street 21
  • Number 04-20
  • Singapore, 609601
  • Singapore
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Acquirer
Vertical(s)
Corporate Office
  • 2 Jurong East, Street 21
  • Number 04-20
  • Singapore, 609601
  • Singapore

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Proteona Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 07-Mar-2022 Completed Generating Revenue
3. Seed Round 24-Feb-2022 Completed Generating Revenue
2. Accelerator/Incubator 01-Jun-2019 Completed Generating Revenue
1. University Spin-Out 01-Jan-2017 Completed Startup
To view Proteona’s complete valuation and funding history, request access »

Proteona Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Proteona’s complete cap table history, request access »

Proteona Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Proteona Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator Minority
Pix Vine Capital Venture Capital Minority
SEEDS Capital Corporate Venture Capital Minority
Xora Innovation Venture Capital Minority
To view Proteona’s complete investors history, request access »

Proteona FAQs

  • When was Proteona founded?

    Proteona was founded in 2017.

  • Where is Proteona headquartered?

    Proteona is headquartered in Singapore, Singapore.

  • What is the size of Proteona?

    Proteona has 14 total employees.

  • What industry is Proteona in?

    Proteona’s primary industry is Biotechnology.

  • Is Proteona a private or public company?

    Proteona is a Private company.

  • What is Proteona’s current revenue?

    The current revenue for Proteona is .

  • How much funding has Proteona raised over time?

    Proteona has raised $3.08M.

  • Who are Proteona’s investors?

    MedTech Innovator, Pix Vine Capital, SEEDS Capital, and Xora Innovation have invested in Proteona.

  • When was Proteona acquired?

    Proteona was acquired on 07-Mar-2022.

  • Who acquired Proteona?

    Proteona was acquired by Singleron.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process